Compliance and Remediation
Bristol-Myers Squibb’s EHS program is founded on our commitment to fully comply with government regulations and our own worldwide corporate directives designed to help protect the environment, our workers and the public.
Violations and Fines
Bristol-Myers Squibb tracks EHS notices of violation, administrative orders and similar notifications (“citations”) worldwide. Whenever a facility does not meet a regulatory requirement, management determines the cause of the noncompliance, takes appropriate corrective measures, and, if necessary, develops an action plan to prevent recurrence of noncompliance.
There were about 80, 90 and 90 government-initiated interactions in 2010, 2011 and 2012 respectively (including, but not limited to, site visits or inspections) at Bristol-Myers Squibb facilities relating to EHS. In 2012 there were about 35 safety and 55 environmental-related government interactions.
The global reporting information provided below reflects only penalties associated with government inspections and does not include, for example, self-reported permit exceedances or minor administrative errors. Also, fines associated with a violation are assigned to the year the fine was paid.
Recent Citations History
The number of EHS citations issued to Bristol-Myers Squibb was 20 in 2010, 19 in 2011 and 17 in 2012. In 2012, ten citations were safety-related and seven were environmental-related. Fines and penalties over $100K paid by the company are disclosed in the annual 10K report filed with the SEC, and in 2010, 2011 and 2012 there were no events that required reporting.
All Bristol-Myers Squibb facilities maintain a spill prevention and response plan to minimize and properly manage any spill or unintended release to the environment.
Bristol-Myers Squibb, like most major industrial companies, is involved in a number of environmental cleanups associated with past activities. We invest resources to achieve cleanup in a manner that is environmentally and financially responsible. We utilize risk management techniques whenever possible to determine the most effective approaches to pursue at each cleanup site. Our prevention-based initiatives, such as product life cycle reviews and best practices transfer, minimize the potential for future environmental impacts.
Bristol-Myers Squibb’s EHS and legal staff routinely interact with Potentially Responsible Parties, government agencies and community groups toward the common goal of providing cost-effective remediation that protects human health and the environment.
Through the end of 2012, Bristol-Myers Squibb estimates its share of the total future costs for these sites is approximately $72.0 million. In 2012, the company paid approximately $5.9 million (excluding legal fees) for investigation and remediation of such matters, including liabilities under CERCLA, state and other regulatory authorities. The company had paid approximately $3.7 million in 2011.
Investigation/remediation projects were ongoing at the following Bristol-Myers Squibb operating facilities in 2012:
- Humacao, Puerto Rico
- New Brunswick, New Jersey
- São Paulo, Brazil
- Swords, Ireland
- Syracuse, New York